28416598|t|EBV MicroRNA BART16 Suppresses Type I IFN Signaling
28416598|a|Type I IFNs play critical roles in orchestrating the antiviral defense by inducing direct antiviral activities and shaping the adaptive immune response. Viruses have evolved numerous strategies to specifically interfere with IFN production or its downstream mediators, thereby allowing successful infection of the host to occur. The prototypic human gammaherpesvirus EBV, which is associated with infectious mononucleosis and malignant tumors, harbors many immune-evasion proteins that manipulate the adaptive and innate immune systems. In addition to proteins, the virus encodes >40 mature microRNAs for which the functions remain largely unknown. In this article, we identify EBV - encoded miR-BART16 as a novel viral immune-evasion factor that interferes with the type I IFN signaling pathway. miR-BART16 directly targets CREB-binding protein, a key transcriptional coactivator in IFN signaling, thereby inducing CREB-binding protein downregulation in EBV-transformed B cells and gastric carcinoma cells. miR-BART16 abrogates the production of IFN - stimulated genes in response to IFN-α stimulation and it inhibits the antiproliferative effect of IFN-α on latently infected BL cells. By obstructing the type I IFN - induced antiviral response, miR-BART16 provides a means to facilitate the establishment of latent EBV infection and enhance viral replication.
28416598	0	3	EBV	T005	UMLS:C0014644
28416598	4	19	MicroRNA BART16	T103	UMLS:C1101610
28416598	31	51	Type I IFN Signaling	T038	UMLS:C2610474
28416598	52	63	Type I IFNs	T103	UMLS:C0021743
28416598	105	122	antiviral defense	T038	UMLS:C1155328
28416598	142	162	antiviral activities	T038	UMLS:C1155328
28416598	167	174	shaping	T082	UMLS:C0332479
28416598	179	203	adaptive immune response	T038	UMLS:C1749719
28416598	205	212	Viruses	T005	UMLS:C0042776
28416598	277	291	IFN production	T038	UMLS:C1819430
28416598	299	319	downstream mediators	T103	UMLS:C0021054
28416598	349	358	infection	T038	UMLS:C3714514
28416598	419	422	EBV	T005	UMLS:C0014644
28416598	449	473	infectious mononucleosis	T038	UMLS:C0021345
28416598	478	494	malignant tumors	T038	UMLS:C0006826
28416598	509	523	immune-evasion	T038	UMLS:C1654934
28416598	524	532	proteins	T103	UMLS:C0033684
28416598	553	561	adaptive	T038	UMLS:C0678209
28416598	573	587	immune systems	T022	UMLS:C0020962
28416598	604	612	proteins	T103	UMLS:C0033684
28416598	618	623	virus	T005	UMLS:C0042776
28416598	643	652	microRNAs	T103	UMLS:C1101610
28416598	730	733	EBV	T005	UMLS:C0014644
28416598	744	754	miR-BART16	T103	UMLS:C1101610
28416598	772	786	immune-evasion	T038	UMLS:C1654934
28416598	819	847	type I IFN signaling pathway	T038	UMLS:C2610474
28416598	849	859	miR-BART16	T103	UMLS:C1101610
28416598	877	897	CREB-binding protein	T103	UMLS:C0256079
28416598	905	932	transcriptional coactivator	T103	UMLS:C1336776
28416598	936	949	IFN signaling	T038	UMLS:C1512827
28416598	968	988	CREB-binding protein	T103	UMLS:C0256079
28416598	989	1003	downregulation	T038	UMLS:C0013081
28416598	1007	1030	EBV-transformed B cells	T017	UMLS:C2699839
28416598	1035	1058	gastric carcinoma cells	T038	UMLS:C1333789
28416598	1060	1070	miR-BART16	T103	UMLS:C1101610
28416598	1099	1102	IFN	T103	UMLS:C0021747
28416598	1105	1115	stimulated	T038	UMLS:C0038337
28416598	1116	1121	genes	T017	UMLS:C0017337
28416598	1137	1142	IFN-α	T103	UMLS:C0002199
28416598	1143	1154	stimulation	T038	UMLS:C0038337
28416598	1175	1192	antiproliferative	T103	UMLS:C0003392
28416598	1203	1208	IFN-α	T103	UMLS:C0002199
28416598	1221	1229	infected	T033	UMLS:C0439663
28416598	1230	1238	BL cells	T017	UMLS:C0004561
28416598	1259	1269	type I IFN	T103	UMLS:C0021743
28416598	1280	1298	antiviral response	T038	UMLS:C1155328
28416598	1300	1310	miR-BART16	T103	UMLS:C1101610
28416598	1370	1373	EBV	T005	UMLS:C0014644
28416598	1374	1383	infection	T038	UMLS:C3714514
28416598	1396	1413	viral replication	T038	UMLS:C0042774